Dyne Therapeutics (NASDAQ:DYN) Director Sells $3,122,168.80 in Stock
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason Rhodes sold 147,760 shares of the business’s stock in a transaction dated Tuesday, June 23rd. The stock was sold at an average price of $21.13, for a total transaction of $3,122,168.80. Following the sale, the director directly owned 1,106,036 shares of the company’s stock, valued […]
26 Jun 13:08 · The Markets Daily